Following IV administration, the estimated half-life of methylene blue is 5-6.5 hours
These locations were selected because they provide adequate subcutaneous tissue depth for reliable absorption, easy access for self-administration, and relatively low risk of hitting blood vessels or nerves
Reporting Side Effects Through the MHRA Yellow Card Scheme Suspected side effects from retatrutide used outside a clinical trial should be reported via the MHRA Yellow Card Scheme
R package version 1.8.0, (2020)
Requires medical eligibility after online consult
- High-dose oral B12 treatment Instead of taking the injection route, a provider may prescribe a high-dose B12 oral treatmenta pill, capsule, or lozenge containing a higher concentration of B12 than your average over-the-counter (OTC) supplement